Designing a binder is an easier process than designing a drug, but it’s a useful proxy. The typical success rate in the field today is between 10% and 15%.
Between 22% and 35% of Claude's designs bound successfully, depending on the setup. Some of its strongest designs bound several times more tightly than the best published de novo binder.